Jury understands that orphan drugs are needed and not readily available. They do not want to damage kid's ability to get what they need...
But they have not dismissed that there was patent infingement of some sort...
Of course, whether there was infringement or not really doesn't matter. What matters is what royalty the Jury will assess on INSM. For example, there could be a finding of infringement, and an assessment of 5%-that would be good for INSM.
Market Data 
Markets 
AI
